BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 21, 2020
View Archived Issues
PDAC subtypes point to targeting strategies
Read More
Natural killer cells dabble in adaptive immunity
Read More
Novel inhaled therapy shows efficacy in preclinical models of SARS-CoV-2 virus infection
Read More
FDA grants approval to initiate COVID-19 study of EB-05
Read More
First patient dosed in phase IIa study of ATI-1777
Read More
European researchers patent new compounds for epilepsy
Read More
AstraZeneca discloses new PROTACs for cancer therapy
Read More
Protecting telomeres prevents lung fibrosis
Read More
First-in-human data presented for ASP-5354
Read More
Chiesi Farmaceutici identifies PI3K inhibitors
Read More
New IRAK-4 inhibitors synthesized by Galapagos
Read More
University of Pennsylvania divulges new CAR T cells for cancer
Read More
Apellis reports 18-month data on pegcetacoplan in advanced geographic atrophy
Read More
Second phase II study of Lyme disease vaccine candidate VLA-15 meets endpoints
Read More
Cardiff Oncology reports phase II results with onvansertib in mCRPC
Read More
Amicus presents interim phase I/II data for AT-GTX-501 gene therapy
Read More
COMPneo predicts carotid artery stenosis
Read More
PRISM3 study of CP-101 oral microbiome drug shows it prevents CDI recurrence
Read More
Phase IIb study in Japan of KW-6356 for Parkinson's disease meets primary endpoint
Read More
FDA grants full approval to Venclexta combinations for newly diagnosed AML
Read More
Union to explore use of UNI-91103 to prevent COVID-19
Read More
Nascent reports in vitro data on pritumumab for COVID-19
Read More
CRISPR Therapeutics reports topline phase I data on CTX-110 for relapsed or refractory NHL
Read More
IntraBio reports further data on IB-1001 for Niemann-Pick disease type C
Read More
Phase III data reported on Merck & Co.'s 15-valent pneumococcal conjugate vaccine V-114
Read More